Back

Prognostic value of global coronary flow reserve improvement after percutaneous coronary intervention in patients with chronic coronary syndrome

26 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Discovering the benefits or stress of CMR Flow Imaging ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Kai Nogami

Mayo Clinic, Rochester (United States of America)

5 More presentations in this session

Presentation thumbnail
Incremental prognostic value of fully automatic LVEF measured at stress using machine learning
Doctor S. Toupin (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Residual ischemia by stress CMR in stable post-STEMI patients. Association with clinical events and implications of guided revascularization
Doctor V. Marcos Garces (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Assessing myocardial microvascular reactivity with a novel MRI imaging approach as an early biomarker of diabetic heart failure
Mr S. Loai (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Safety and incremental prognostic value of stress CMR in patients with known chronic kidney disease
Doctor T. Pezel (Paris, FR)
Abstract Slides
Presentation thumbnail
Coronary vascular function in females with history of hypertensive disorders of pregnancy an oxygenation-sensitive cardiovascular magnetic resonance imaging study
Doctor E. Hillier (Montreal, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Discovering the benefits or stress of CMR

The Event

Event poster

ESC Congress 2023

26 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
TDE-derived impaired post-PCI Coronary flow velocity reserve predicts MACE in patients who underwent LAD PCI
thumbnail
Congress Presentation
Impaired myocardial flow reserve from 82-rubidium positron emission tomography predicts survival benefit from revascularization: a multicenter registry study
thumbnail
Congress Presentation
Prognostic significance of endogenous-type coronary microvascular dysfunction following elective percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources